Global Transdermal Drug Delivery System Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Transdermal Drug Delivery System Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

According to APO Research, The global Transdermal Drug Delivery System market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Transdermal Drug Delivery System is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Transdermal Drug Delivery System include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku and Bayer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Transdermal Drug Delivery System, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Transdermal Drug Delivery System, also provides the value of main regions and countries. Of the upcoming market potential for Transdermal Drug Delivery System, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Transdermal Drug Delivery System revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Transdermal Drug Delivery System market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Transdermal Drug Delivery System company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Transdermal Drug Delivery System segment by Company

Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Transdermal Drug Delivery System segment by Type

Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Transdermal Drug Delivery System segment by Application

OTC
Rx
Transdermal Drug Delivery System segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Transdermal Drug Delivery System status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Transdermal Drug Delivery System key companies, revenue, market share, and recent developments.
3. To split the Transdermal Drug Delivery System breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Transdermal Drug Delivery System market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Transdermal Drug Delivery System significant trends, drivers, influence factors in global and regions.
6. To analyze Transdermal Drug Delivery System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Transdermal Drug Delivery System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Transdermal Drug Delivery System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Transdermal Drug Delivery System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Transdermal Drug Delivery System industry.
Chapter 3: Detailed analysis of Transdermal Drug Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Transdermal Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Transdermal Drug Delivery System in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Transdermal Drug Delivery System Market Size, 2019 VS 2023 VS 2030
1.3 Global Transdermal Drug Delivery System Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Transdermal Drug Delivery System Market Dynamics
2.1 Transdermal Drug Delivery System Industry Trends
2.2 Transdermal Drug Delivery System Industry Drivers
2.3 Transdermal Drug Delivery System Industry Opportunities and Challenges
2.4 Transdermal Drug Delivery System Industry Restraints
3 Transdermal Drug Delivery System Market by Company
3.1 Global Transdermal Drug Delivery System Company Revenue Ranking in 2023
3.2 Global Transdermal Drug Delivery System Revenue by Company (2019-2024)
3.3 Global Transdermal Drug Delivery System Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Transdermal Drug Delivery System Company Manufacturing Base & Headquarters
3.5 Global Transdermal Drug Delivery System Company, Product Type & Application
3.6 Global Transdermal Drug Delivery System Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Transdermal Drug Delivery System Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Transdermal Drug Delivery System Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 Transdermal Drug Delivery System Market by Type
4.1 Transdermal Drug Delivery System Type Introduction
4.1.1 Fentanyl
4.1.2 Nitroglycerin
4.1.3 Estradiol
4.1.4 Nicotine
4.1.5 Other
4.2 Global Transdermal Drug Delivery System Sales Value by Type
4.2.1 Global Transdermal Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Transdermal Drug Delivery System Sales Value by Type (2019-2030)
4.2.3 Global Transdermal Drug Delivery System Sales Value Share by Type (2019-2030)
5 Transdermal Drug Delivery System Market by Application
5.1 Transdermal Drug Delivery System Application Introduction
5.1.1 OTC
5.1.2 Rx
5.2 Global Transdermal Drug Delivery System Sales Value by Application
5.2.1 Global Transdermal Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Transdermal Drug Delivery System Sales Value by Application (2019-2030)
5.2.3 Global Transdermal Drug Delivery System Sales Value Share by Application (2019-2030)
6 Transdermal Drug Delivery System Market by Region
6.1 Global Transdermal Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Transdermal Drug Delivery System Sales Value by Region (2019-2030)
6.2.1 Global Transdermal Drug Delivery System Sales Value by Region: 2019-2024
6.2.2 Global Transdermal Drug Delivery System Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Transdermal Drug Delivery System Sales Value (2019-2030)
6.3.2 North America Transdermal Drug Delivery System Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Transdermal Drug Delivery System Sales Value (2019-2030)
6.4.2 Europe Transdermal Drug Delivery System Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Transdermal Drug Delivery System Sales Value (2019-2030)
6.5.2 Asia-Pacific Transdermal Drug Delivery System Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Transdermal Drug Delivery System Sales Value (2019-2030)
6.6.2 Latin America Transdermal Drug Delivery System Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Transdermal Drug Delivery System Sales Value (2019-2030)
6.7.2 Middle East & Africa Transdermal Drug Delivery System Sales Value Share by Country, 2023 VS 2030
7 Transdermal Drug Delivery System Market by Country
7.1 Global Transdermal Drug Delivery System Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Transdermal Drug Delivery System Sales Value by Country (2019-2030)
7.2.1 Global Transdermal Drug Delivery System Sales Value by Country (2019-2024)
7.2.2 Global Transdermal Drug Delivery System Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.3.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.4.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.5.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.6.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.7.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.8.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.9.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.10.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.11.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.12.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.13.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.14.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.15.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.16.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.17.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.18.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.19.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.20.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Transdermal Drug Delivery System Sales Value Growth Rate (2019-2030)
7.21.2 Global Transdermal Drug Delivery System Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Transdermal Drug Delivery System Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Hisamitsu
8.1.1 Hisamitsu Comapny Information
8.1.2 Hisamitsu Business Overview
8.1.3 Hisamitsu Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.1.4 Hisamitsu Transdermal Drug Delivery System Product Portfolio
8.1.5 Hisamitsu Recent Developments
8.2 Mylan
8.2.1 Mylan Comapny Information
8.2.2 Mylan Business Overview
8.2.3 Mylan Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.2.4 Mylan Transdermal Drug Delivery System Product Portfolio
8.2.5 Mylan Recent Developments
8.3 GSK
8.3.1 GSK Comapny Information
8.3.2 GSK Business Overview
8.3.3 GSK Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.3.4 GSK Transdermal Drug Delivery System Product Portfolio
8.3.5 GSK Recent Developments
8.4 Novartis
8.4.1 Novartis Comapny Information
8.4.2 Novartis Business Overview
8.4.3 Novartis Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.4.4 Novartis Transdermal Drug Delivery System Product Portfolio
8.4.5 Novartis Recent Developments
8.5 Teve (Actavis)
8.5.1 Teve (Actavis) Comapny Information
8.5.2 Teve (Actavis) Business Overview
8.5.3 Teve (Actavis) Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.5.4 Teve (Actavis) Transdermal Drug Delivery System Product Portfolio
8.5.5 Teve (Actavis) Recent Developments
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Comapny Information
8.6.2 Johnson & Johnson Business Overview
8.6.3 Johnson & Johnson Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.6.4 Johnson & Johnson Transdermal Drug Delivery System Product Portfolio
8.6.5 Johnson & Johnson Recent Developments
8.7 Lohmann
8.7.1 Lohmann Comapny Information
8.7.2 Lohmann Business Overview
8.7.3 Lohmann Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.7.4 Lohmann Transdermal Drug Delivery System Product Portfolio
8.7.5 Lohmann Recent Developments
8.8 Teikoku Seiyaku
8.8.1 Teikoku Seiyaku Comapny Information
8.8.2 Teikoku Seiyaku Business Overview
8.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Product Portfolio
8.8.5 Teikoku Seiyaku Recent Developments
8.9 Bayer
8.9.1 Bayer Comapny Information
8.9.2 Bayer Business Overview
8.9.3 Bayer Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.9.4 Bayer Transdermal Drug Delivery System Product Portfolio
8.9.5 Bayer Recent Developments
8.10 Lingrui
8.10.1 Lingrui Comapny Information
8.10.2 Lingrui Business Overview
8.10.3 Lingrui Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.10.4 Lingrui Transdermal Drug Delivery System Product Portfolio
8.10.5 Lingrui Recent Developments
8.11 Sanofi
8.11.1 Sanofi Comapny Information
8.11.2 Sanofi Business Overview
8.11.3 Sanofi Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.11.4 Sanofi Transdermal Drug Delivery System Product Portfolio
8.11.5 Sanofi Recent Developments
8.12 Qizheng
8.12.1 Qizheng Comapny Information
8.12.2 Qizheng Business Overview
8.12.3 Qizheng Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.12.4 Qizheng Transdermal Drug Delivery System Product Portfolio
8.12.5 Qizheng Recent Developments
8.13 Endo
8.13.1 Endo Comapny Information
8.13.2 Endo Business Overview
8.13.3 Endo Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.13.4 Endo Transdermal Drug Delivery System Product Portfolio
8.13.5 Endo Recent Developments
8.14 Huarun 999
8.14.1 Huarun 999 Comapny Information
8.14.2 Huarun 999 Business Overview
8.14.3 Huarun 999 Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.14.4 Huarun 999 Transdermal Drug Delivery System Product Portfolio
8.14.5 Huarun 999 Recent Developments
8.15 Haw Par
8.15.1 Haw Par Comapny Information
8.15.2 Haw Par Business Overview
8.15.3 Haw Par Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.15.4 Haw Par Transdermal Drug Delivery System Product Portfolio
8.15.5 Haw Par Recent Developments
8.16 Nichiban
8.16.1 Nichiban Comapny Information
8.16.2 Nichiban Business Overview
8.16.3 Nichiban Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.16.4 Nichiban Transdermal Drug Delivery System Product Portfolio
8.16.5 Nichiban Recent Developments
8.17 Mentholatum
8.17.1 Mentholatum Comapny Information
8.17.2 Mentholatum Business Overview
8.17.3 Mentholatum Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.17.4 Mentholatum Transdermal Drug Delivery System Product Portfolio
8.17.5 Mentholatum Recent Developments
8.18 Laboratoires Genevrier
8.18.1 Laboratoires Genevrier Comapny Information
8.18.2 Laboratoires Genevrier Business Overview
8.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Revenue and Gross Margin (2019-2024)
8.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Product Portfolio
8.18.5 Laboratoires Genevrier Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings